← Back to catalogue
Research draft

rubella

vr.tr.rubella · XCT.QLT

Enable an AI agent to recognise a rubella-related disease record, assess its evidential and clinical state, and identify appropriate clinical or public-health follow-up.

Thing Registry Cross-cutting context

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

recalled by Codex without web access - no source was read

Researched by: Codex

Purpose and description

Enable an AI agent to recognise a rubella-related disease record, assess its evidential and clinical state, and identify appropriate clinical or public-health follow-up.

Rubella is a contagious infection caused by rubella virus, often asymptomatic or associated with a mild fever and rash, that can cause miscarriage, fetal death or congenital abnormalities when acquired during pregnancy, particularly early pregnancy.

It can be Organise rubella evidence into an explicitly provisional or definition-based case classification.; Identify missing specimens, dates or interpretive context for qualified clinical or laboratory review.; Connect maternal and infant evidence while preserving distinct infection and outcome states.; Flag pregnancy-related exposure or suspected infection for timely specialist assessment.; Identify applicable notification, contact-management and prevention guidance using jurisdiction and date.; Revise assessments as evidence arrives while preserving previous classifications and their rationale..

Distinguishing features

The referent is the disease rubella, rather than the rubella virus, a vaccine product or an antibody-test result.

A rash description or the historical name German measles does not establish rubella or make it equivalent to measles.

Evidence of immunity must be distinguished from evidence of current or recent infection; an antibody result requires its assay and timing context.

Acquired infection, maternal infection, congenital infection and congenital rubella syndrome require distinct classifications connected by explicit relationships.

Absence of reported symptoms cannot by itself establish absence of infection.

Scope

+ Recognition and classification of suspected or confirmed acquired rubella

+ Exposure, infection and symptom timelines, including asymptomatic infection

+ Interpretation context for rubella-specific laboratory evidence

+ Maternal infection, fetal exposure, congenital infection and congenital rubella syndrome as distinct related states

+ Rubella susceptibility, prevention context and public-health follow-up

- Rubella virus taxonomy, genome and laboratory propagation

- Measles and other rash illnesses except as differential diagnoses

- Vaccine product manufacture, procurement and complete immunisation schedules

- Comprehensive pregnancy management and management of individual congenital impairments

- General outbreak-management systems and healthcare-service operations

Characteristics

Disease context
acquired infection | maternal infection | congenital infection | congenital rubella syndrome evaluation | unresolved Determines which evidence, outcomes and relationships the agent must examine.
Case classification
suspected | probable | confirmed | discarded | unclassified, with governing definition and version Preserves the distinction between a provisional assessment and classification under a particular surveillance system.
Clinical presentation
reported symptoms and signs, explicitly asymptomatic, or symptom status unknown Supports recognition without treating nonspecific symptoms or missing observations as confirmation.
Event timing
dated exposure, rash onset, specimen collection and assessment events; intervals in days with uncertainty Connects exposure assessment, test interpretation and follow-up to the relevant time window.
Laboratory evidence
assay, specimen, collection date, reported result, interpretation and laboratory reference criteria Prevents a positive, negative or equivocal result from being interpreted without its methodological context.
Immunity assessment
evidence of immunity | susceptible | indeterminate | unknown, with evidence basis Separates prevention-related assessment from diagnosis of an acute episode.
Pregnancy timing
gestational age in weeks and days at relevant events, with dating method and uncertainty Makes maternal infection and fetal-risk assessment temporally interpretable.
Maternal-infant linkage
linked maternal, pregnancy, fetal and infant records with relationship certainty Connects related evidence without assigning the mother's diagnosis automatically to the fetus or infant.
Epidemiological linkage
documented contact, shared exposure, travel association or outbreak linkage, with dates and evidence Supports transmission assessment without assuming that temporal proximity proves transmission.

Where this came from

wikidata · CC0 1.0

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 6 bundles · 11 layers · 19 findings · 32 questions.

Rubella recognition Establishes which rubella disease state is being considered and why.

Rubella must be distinguished from other rash illnesses and from records that concern only immunity or exposure.

Disease referent

Separates disease episodes from virus, vaccination and immunity records.

Meaning of the rubella record

Record whether rubella denotes an assessed infection, a historical diagnosis, a congenital condition or an unresolved mention.

  1. Does this record describe acquired rubella, congenital infection, congenital rubella syndrome or merely an exposure or immunity assessment? definition
  2. What source establishes the intended meaning of the rubella label? provenance

Clinical recognition

Captures the presentation and competing explanations without equating clinical resemblance with confirmation.

Presentation and differential

Record observed rash, lymph-node findings, joint symptoms and other relevant observations, including whether symptoms were assessed at all.

  1. Which symptoms and signs were observed, on what dates, and was the person explicitly assessed as asymptomatic? measurement
  2. What evidence distinguishes rubella from measles, parvovirus B19 infection or other plausible causes of this presentation? boundary
Rubella diagnostic evidence Connects laboratory observations and case definitions to a defensible assessment.

Rubella test results have different implications for acute infection and immunity, and require timing and assay context.

Specimens and assays

Preserves the evidence needed to interpret molecular and serological results.

Test interpretation context

Record specimen type, assay, collection timing and relevant vaccination history alongside reported results and laboratory interpretation.

  1. Which molecular, IgM, IgG or avidity tests were performed, using what specimens and at what intervals from exposure or symptom onset? measurement
  2. What laboratory guidance addresses the result's limitations, including equivocal findings, false positives or recent vaccination? provenance
  3. Does the available evidence warrant additional testing or reference-laboratory interpretation under applicable guidance? action

Classification and revision

Separates clinical judgment from formal surveillance classification.

Definition-based case status

Attach each case classification to the evidence and definition supporting it, retaining unresolved contradictions.

  1. Which jurisdiction's rubella case definition and version govern this classification? provenance
  2. Which criteria are met, missing or contradicted, and how does that affect the current classification? definition
Rubella exposure and transmission Represents possible acquisition and onward exposure through dated, evidenced relationships.

Rubella assessment requires an exposure timeline that remains useful when symptoms or the source of infection are uncertain.

Acquisition timeline

Connects possible contacts, travel and onset events without inventing a transmission chain.

Plausible exposure history

Record candidate exposure events and their temporal compatibility with the assessed episode.

  1. What contacts, locations and travel dates could explain acquisition, and which details are documented rather than recalled or inferred? provenance
  2. Are the proposed exposures compatible with the incubation interval specified by the selected authoritative guidance? measurement

Onward exposure assessment

Identifies potentially exposed people using the relevant disease context and guidance.

Contact window and priority

Record the basis for the assessed infectious interval and identify contacts whose pregnancy or susceptibility status affects follow-up.

  1. What infectious interval applies to this acquired or congenital infection assessment, and how was it derived? provenance
  2. Which contacts fall within that interval, and which need prompt assessment because pregnancy or susceptibility is known or unresolved? action
Maternal and congenital rubella Links pregnancy-related infection evidence to fetal and infant assessments without collapsing them into one diagnosis.

Maternal infection, fetal infection and congenital rubella syndrome are different propositions requiring distinct evidence.

Maternal infection in pregnancy

Places exposure and infection evidence within a documented gestational timeline.

Gestationally timed maternal evidence

Record pregnancy dating, maternal evidence and uncertainty relevant to specialist assessment.

  1. What was the estimated gestational age at exposure, illness onset and specimen collection, and how certain is that dating? measurement
  2. What evidence supports maternal infection rather than exposure alone or pre-existing immunity? boundary
  3. Which unresolved findings require specialist review before pregnancy-specific conclusions are recorded? action

Congenital infection and outcomes

Separates evidence of congenital infection from the findings used to assess congenital rubella syndrome.

Infant infection versus syndrome

Record infant-specific laboratory evidence and assessed hearing, ocular, cardiac and other relevant findings, with their timing and attribution.

  1. What evidence establishes congenital infection independently of the maternal diagnosis? boundary
  2. Which findings support congenital rubella syndrome under the selected definition, and which assessments remain incomplete? definition
  3. What follow-up is indicated for outcomes that cannot be settled at the initial infant assessment? action
Rubella prevention and response Connects susceptibility and case evidence to applicable prevention and public-health actions.

Agents must distinguish immunity assessment from acute diagnosis and ground response decisions in current local guidance.

Susceptibility and vaccination context

Captures the evidence used to assess protection and the context needed for vaccination review.

Evidence of immunity

Record documented vaccination and laboratory evidence separately, identifying the rule used to interpret them.

  1. What documented vaccination or laboratory evidence supports immunity, and what acceptance criteria apply? provenance
  2. Does pregnancy status or another relevant clinical circumstance require qualified review of vaccination eligibility or timing? action

Notification and follow-up

Tracks the response warranted by the current assessment and its governing authority.

Guidance-linked response

Record applicable reporting, infection-control and contact-follow-up requirements, including responsible parties and completion state.

  1. Which current local requirements apply to reporting and managing this suspected or confirmed rubella case? provenance
  2. What notification, infection-control or contact-follow-up actions are due, who owns them, and what evidence shows completion? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.

A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.

Reported evidence

Findings from the breadth pass, kept separate from the structural claims.

Check these first

Recalled without web access and unsourced; every item is a lead to verify.

  • This is recalled knowledge, not a source-reviewed account.
  • The entry is interpreted as the infectious disease, rather than the virus or congenital rubella syndrome alone.
  • Current regional elimination status, vaccination schedules and reporting rules require verification; antibody thresholds depend on the assay.
  1. Which of these check these first hold for the sense of rubella this model covers, and on what evidence? provenance

Kinds and varieties

Recalled without web access and unsourced; every item is a lead to verify.

  • Acquired rubella
  • Congenital rubella infection
  1. Which of these kinds and varieties hold for the sense of rubella this model covers, and on what evidence? provenance

Identifiers and schemes

Recalled without web access and unsourced; every item is a lead to verify.

  • ICD-10 - B06 - Rubella category; congenital rubella is classified separately.
  • ICD-10 - P35.0 - Congenital rubella syndrome.
  1. Which of these identifiers and schemes hold for the sense of rubella this model covers, and on what evidence? provenance

Standards and regulation

Recalled without web access and unsourced; every item is a lead to verify.

  • World Health Organization surveillance standards for rubella and congenital rubella syndrome.
  • World Health Organization position papers on rubella vaccines.
  • National communicable-disease notification requirements; reporting obligations depend on jurisdiction.
  1. Which of these standards and regulation hold for the sense of rubella this model covers, and on what evidence? provenance

Real-world use

Recalled without web access and unsourced; every item is a lead to verify.

  • Routine immunisation programmes use rubella-containing vaccines, commonly measles-mumps-rubella vaccine.
  • Public-health surveillance tracks rubella cases and congenital rubella syndrome.
  • Laboratory testing supports diagnosis and assessment of immunity.
  • Pregnancy-related exposure assessments address the risk of congenital infection.
  1. Which of these real-world use hold for the sense of rubella this model covers, and on what evidence? provenance

Typical measurements

Recalled without web access and unsourced; every item is a lead to verify.

  • Incubation period - 12-23 - days
  • Typical rash duration - Approximately 3 - days
  • Usual infectious period in acquired rubella relative to rash onset - Approximately 7 days before to 7 days after - days
  1. Which of these typical measurements hold for the sense of rubella this model covers, and on what evidence? provenance

Failure modes and hazards

Recalled without web access and unsourced; every item is a lead to verify.

  • Infection during early pregnancy can cause miscarriage, fetal death or congenital rubella syndrome, including hearing impairment, eye abnormalities and congenital heart disease.
  • Mild or asymptomatic infections can escape recognition and sustain transmission.
  • Clinical diagnosis from rash alone is unreliable because other infections can look similar.
  • Rubella IgM results can be misleading because of false positives or persistent antibodies; interpretation requires clinical and laboratory context.
  • Gaps in population immunity permit outbreaks and exposure of susceptible pregnant people.
  1. Which of these failure modes and hazards hold for the sense of rubella this model covers, and on what evidence? provenance

Regional variation

Recalled without web access and unsourced; every item is a lead to verify.

  • Vaccine coverage and historical vaccine introduction differ between countries and birth cohorts.
  • Some regions have achieved verified elimination of endemic rubella transmission, while transmission persists elsewhere; elimination does not prevent imported cases.
  • Immunity-screening policies, surveillance capacity and notification requirements differ by jurisdiction.
  1. Which of these regional variation hold for the sense of rubella this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Recalled without web access and unsourced; every item is a lead to verify.

  • Measles - Caused by measles virus rather than rubella virus; it is a distinct infection despite both producing fever and rash.
  • Rubella virus - The infectious agent; rubella denotes the infection or disease it causes.
  • Congenital rubella syndrome - The pattern of congenital abnormalities resulting from infection in utero; congenital rubella infection can occur without the syndrome.
  • Roseola - A separate childhood illness usually caused by human herpesvirus 6 or 7, typically with rash appearing as fever subsides.
  1. Which of these neighbouring kinds and how to tell them apart hold for the sense of rubella this model covers, and on what evidence? provenance

What the second pass must settle

  • Does an existing Vercy world model already own rubella or congenital rubella syndrome, requiring this registry entry to link to it rather than duplicate it?
  • Which authoritative clinical and surveillance definitions should anchor the model, and how should jurisdiction-specific differences be represented?
  • Which assay-specific interpretation rules and specimen-timing recommendations should govern uncertain or conflicting rubella laboratory evidence?
  • How should congenital infection and congenital rubella syndrome be represented within this entry while preserving any existing registry boundaries?
  • Which current guidance should govern pregnancy-related assessment, congenital-infection follow-up and infectious-period decisions, and how should updates be maintained?